The ROR1-reactive HTLs selectively recognized ROR1+ HNSCC cell lines in an HLA-DR-restricted manner, indicating that the ROR1403–417 epitope is naturally processed and presented by tumor cells. The gene discussed is ROR1; the disease is neoplasm.